Functional Cardiac Presentations: Clinical Management Considerations
Given the frequency of functional cardiac presentations and associated risks of iatrogenic harm, clinicians should be proficient in recognizing and appropriately managing patients presenting with functional cardiac symptoms, emphasizing the importance of comprehensive diagnostic evaluations and patient-centered care approaches.
October 2021
Cardiovascular Risk in Gestational Diabetes: Long-Term Implications
Women with gestational diabetes mellitus have a significantly increased risk of calcification of the cardiac arteries, even after maintaining normal blood glucose levels post-pregnancy, highlighting the importance of cardiovascular risk assessment and preventive measures in this population.
October 2021
Antipsychotic-Cardiovascular Drug Interactions: Polypharmacy Risks
Polypharmacy involving antipsychotics and cardiovascular drugs increases the risk of potential adverse drug interactions, highlighting the importance of medication reconciliation and monitoring in patients receiving multiple pharmacological agents.
August 2021
Dental Infection and Morbidity in Cardiac Valve Surgery: Preoperative Screening Recommendations
Preoperative dental screening is recommended for patients undergoing cardiac valve surgery to mitigate the risk of postoperative complications associated with dental infections, emphasizing the importance of multidisciplinary collaboration in perioperative care management.
July 2021
Stroke as a Complication of COVID-19 in Young Patients: Incidence and Mortality Rates
Approximately two in every 100 patients hospitalized with COVID-19 will suffer a stroke, with a significant mortality rate, highlighting the need for vigilance and prompt management of stroke risk factors in young COVID-19 patients.
June 2021
Adrenal Crisis in Elderly Patients: Recognition and Management Challenges
Adrenal crises represent serious manifestations of adrenal insufficiency in elderly patients, necessitating prompt recognition, hospitalization, and intensive management to mitigate associated risks of cardiovascular events, acute kidney injury, and mortality, highlighting the importance of heightened clinical vigilance in this vulnerable population.
April 2021
Cardiovascular Considerations during the COVID-19 Pandemic: Implications for Patient Management
COVID-19's cardiovascular impact and potential consequences in patients with established cardiovascular disease necessitate comprehensive risk assessment, vigilant monitoring, and individualized management strategies to optimize clinical outcomes and mitigate cardiovascular complications in affected individuals.
Februery 2021
Saturated Fats and Health: Revisiting Dietary Recommendations
Reduction in saturated fat intake does not confer beneficial effects on cardiovascular disease and total mortality, with protective effects against stroke observed instead, challenging traditional dietary guidelines and highlighting the need for nuanced dietary recommendations based on updated evidence.
Februery 2021
Decline in Stroke Imaging Studies during the Pandemic: Implications for Stroke Care
A 40% reduction in stroke imaging studies during the pandemic underscores the impact of healthcare disruptions on stroke care delivery, highlighting the need for enhanced public awareness, telemedicine initiatives, and streamlined care pathways to ensure timely stroke evaluation and treatment.
January 2021
Effectiveness of Exercise Training in Hypertensive Patients: Comparative Analysis of Training Modalities
High-intensity interval training demonstrates comparable efficacy to moderate-intensity continuous training in improving thrombotic markers and microRNA levels in hypertensive patients, supporting its role as an effective exercise modality in hypertension management and cardiovascular risk reduction.
January 2021
